# Nepal Chemicals Export Opportunities (HS 28-38)

![Yugalinks](https://www.yugalinks.com/trade/yugalinks-logo-v3-dark-mode.webp)

> Yugalinks sector export playbook

Explore Nepal HS 28-38 chemicals export opportunities, product portfolio, buyer markets, growth signals, and diversification opportunities.

## Overview

- Exporter: Nepal (NPL)
- Sector: Chemicals
- HS chapters: HS 28-38
- Latest trade year: 2024
- Sector exports: $1.4M
- Products: 26
- Buyer markets: 28
- Average CAGR: +12.9%
- Global sector size: $572.9B

## Product portfolio

| Product | Global size | Your exports | Opportunity | CAGR | Markets | Share |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $288.9B | $15.6K | $100.2B | -0.3% | 20 | +0.0% |
| HS 300215 - Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale | $153.4B | $500.8K | $58.2B | +30.6% | 18 | +0.0% |
| HS 300212 - Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions | $29.5B | $374.3K | $16.6B | +32.3% | 7 | +0.0% |
| HS 330499 - Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $28.8B | $65.2K | $11.8B | -4.8% | 10 | +0.0% |
| HS 382200 - Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $22.3B | $74.0K | $9.9B | +7.6% | 8 | +0.0% |
| HS 300290 - Toxins, cultures of micro-organisms (excluding yeasts) and similar products | $6.3B | $86.0K | $3.8B | +7.6% | 5 | +0.0% |
| HS 330300 - Perfumes and toilet waters | $6.3B | $8.9K | $3.6B | +3.5% | 5 | +0.0% |
| HS 330210 - Odoriferous substances and mixtures: of a kind used in the food or drink industries | $2.4B | $267.8 | $3.6B | +5.0% | 1 | +0.0% |
| HS 382499 - Chemical products, mixtures and preparations: n.e.c. heading 3824 | $3.9B | $10.8 | $2.9B | -47.5% | 2 | +0.0% |
| HS 300214 - Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, mixed, put up in measured doses or in forms or packings for retail sale | $6.9B | $559.5 | $2.4B | +31.4% | 1 | +0.0% |
| HS 300390 - Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | $3.8B | $348.2 | $2.2B | +25.0% | 2 | +0.0% |
| HS 340220 - Washing and cleaning preparations: surface-active, whether or not containing soap (excluding those of heading no. 3401), put up for retail sale | $2.3B | $378.3 | $2.1B | -0.1% | 2 | +0.0% |
| HS 300420 - Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | $3.8B | $2.2 | $2.0B | +6.1% | 1 | +0.0% |
| HS 300220 - Vaccines: for human medicine | $1.8B | $13.0 | $1.6B | -45.6% | 1 | +0.0% |
| HS 370790 - Photographic goods: chemical preparations other than sensitised emulsions, put up in measured portions or put up for retail sale in a form ready for use | $979.7M | $1.5K | $1.0B | +64.7% | 1 | +0.0% |
| HS 294190 - Antibiotics: n.e.c. in heading no. 2941 | $883.6M | $2.8K | $990.0M | -36.3% | 1 | +0.0% |
| HS 293499 - Nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934 | $895.5M | $3.4K | $959.0M | -53.3% | 1 | +0.0% |
| HS 340130 - Organic surface-active products and preparations for washing the skin, in the form of liquid or cream and put up for retail sale, whether or not containing soap | $1.5B | $3.3K | $925.9M | +110.5% | 2 | +0.0% |
| HS 330290 - Odoriferous substances and mixtures: used as raw materials in industries other than the food or drink industries | $1.3B | $10.1 | $803.3M | -17.2% | 1 | +0.0% |
| HS 293299 - Heterocyclic compounds: with oxygen hetero-atom(s) only, no lactones or unfused furan rings (hydrogenated or not) in the structure, other than isosafrole, 1-(1,3-benzodiaxol-5-yl) propan-2-one, piperonal, safrole, tetrahydrocannabinols (all isomers) | $723.6M | $273.8K | $674.0M | -2.6% | 1 | +0.1% |
| HS 300213 - Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale | $961.6M | $232.2 | $643.7M | +26.3% | 1 | +0.0% |
| HS 330749 - Perfumes and deodorizors: perfuming or deodorizing preparations for rooms, (excluding those which operate by burning) | $676.1M | $5.2K | $579.1M | +3.9% | 1 | +0.0% |
| HS 310210 - Fertilizers, mineral or chemical: nitrogenous, urea, whether or not in aqueous solution | $2.0B | $52.6 | $549.1M | +107.2% | 1 | +0.0% |
| HS 330410 - Cosmetic and toilet preparations: lip make-up | $463.2M | $2.0K | $490.8M | +35.5% | 1 | +0.0% |
| HS 350691 - Adhesives: prepared, based on polymers of heading 3901 to 3913 or on rubber | $1.2B | $1.9K | $489.3M | +57.0% | 1 | +0.0% |
| HS 320890 - Paints and varnishes: based on polymers n.e.s. in heading no. 3208, dispersed or dissolved in a non-aqueous medium | $929.3M | $237.9 | $442.0M | +46.0% | 1 | +0.0% |

## Best markets

- USA, Puerto Rico and US Virgin Islands (USA): $59.2B calculated opportunity across 12 products.
- Switzerland, Liechtenstein (CHE): $33.9B calculated opportunity across 3 products.
- Germany (DEU): $21.4B calculated opportunity across 10 products.
- China (CHN): $20.2B calculated opportunity across 12 products.
- Netherlands (NLD): $11.7B calculated opportunity across 4 products.
- United Kingdom (GBR): $9.9B calculated opportunity across 7 products.
- Canada (CAN): $8.6B calculated opportunity across 5 products.
- France (FRA): $7.2B calculated opportunity across 4 products.
- Belgium (BEL): $7.0B calculated opportunity across 1 products.
- Ireland (IRL): $5.0B calculated opportunity across 2 products.
- Italy (ITA): $4.9B calculated opportunity across 1 products.
- Austria (AUT): $4.8B calculated opportunity across 3 products.

## Growth stars

- HS 340130: +110.5% average CAGR, $925.9M calculated opportunity.
- HS 310210: +107.2% average CAGR, $549.1M calculated opportunity.
- HS 370790: +64.7% average CAGR, $1.0B calculated opportunity.
- HS 350691: +57.0% average CAGR, $489.3M calculated opportunity.
- HS 320890: +46.0% average CAGR, $442.0M calculated opportunity.
- HS 330410: +35.5% average CAGR, $490.8M calculated opportunity.
- HS 300212: +32.3% average CAGR, $16.6B calculated opportunity.
- HS 300214: +31.4% average CAGR, $2.4B calculated opportunity.
- HS 300215: +30.6% average CAGR, $58.2B calculated opportunity.
- HS 300213: +26.3% average CAGR, $643.7M calculated opportunity.

## Diversification opportunities

- HS 300490: 20 buyer markets, $100.2B calculated opportunity.
- HS 300215: 18 buyer markets, $58.2B calculated opportunity.
- HS 330499: 10 buyer markets, $11.8B calculated opportunity.
- HS 382200: 8 buyer markets, $9.9B calculated opportunity.
- HS 300212: 7 buyer markets, $16.6B calculated opportunity.
- HS 300290: 5 buyer markets, $3.8B calculated opportunity.
- HS 330300: 5 buyer markets, $3.6B calculated opportunity.
- HS 382499: 2 buyer markets, $2.9B calculated opportunity.
- HS 300390: 2 buyer markets, $2.2B calculated opportunity.
- HS 340220: 2 buyer markets, $2.1B calculated opportunity.

## Method

Reported trade observations and calculated indicators are shown separately. Validate buyers, standards, logistics, pricing, and competition before acting. [Read the Yugalinks methodology](https://www.yugalinks.com/methodology).

## Data sources

- Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/)
- CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf)

This page presents derived Yugalinks views of reported observations and calculated indicators.